Phibro Animal Health Corp (FRA:PB8)
€ 23.8 1.8 (8.18%) Market Cap: 952.18 Mil Enterprise Value: 1.35 Bil PE Ratio: 59.42 PB Ratio: 4.00 GF Score: 72/100

Phibro Animal Health Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 08:15PM GMT
Release Date Price: €21.6 (-2.70%)
Michael Leonidovich Ryskin
BofA Securities, Research Division - Associate

All right. Thank you for joining us for our next session. My name is Mike Ryskin. I'm on the life science tools and diagnostics team, also covering animal health. Joining me here today from the team is the Senior Analyst, Derik De Bruin. And for health session, we're joined by Phibro Animal Health. With us here, we have Jack Bendheim, Chairman and CEO; and also Danny Bendheim and Damian Finio. Thank you for being with us, gentlemen. Appreciate you taking the time.

I think just to get the ball rolling a little bit, you guys reported earnings just this past Thursday, Friday, the fiscal 3Q for you, very strong results. Maybe just a little bit of a quick background. Sort of can you give us a recap of the main points from the earnings front sort of what you thought was the most notable point.

Damian Finio
Phibro Animal Health Corporation - CFO

Yes. Let me start. So yes, we had a good third quarter. And we also put out our guide for the fourth quarter and what would be our full year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot